We are the Artful Dodgers of the globalised world, experts at ducking and diving - but even the Dodger gets caught in the end ...
Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...
According to NOAA with severe weather fatalities each year on average. Number 3 on the list is straight line wind damage at 57 fatalities each year in the United States while number two on the ...
Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...
We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look ...
Regenxbio is ranked Strong Buy due to low EV, strong partnerships, royalty income, bullish trends, and buyout potential.
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
ARDC Ares Dynamic Credit Allocation Fund, Inc.
RSF RiverNorth Capital and Income Fund, Inc.
GDV.TO Global Dividend Growth Split Corp.
QVC Group on Thursday announced a reorganization, which resulted in the elimination of about 900 roles across its HSN, QVC U.S. and its Global Shared Services teams. The company, which recently ...
Mutual funds remain at T. Rowe Price's core while Fidelity continues to evolve Amanda Jackson has expertise in personal finance, investing, and social services. She is a library professional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results